Stock CSAM OMDA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Omda

Equities

CSAM

NO0010894512

Advanced Medical Equipment & Technology

Market Closed - Oslo Bors
Other stock markets
 08:15:00 26/06/2024 pm IST 		5-day change 1st Jan Change
36.1 NOK +0.28% Intraday chart for Omda -5.00% -2.43%
05/06 Omda AS (OB:OMDA) commences an Equity Buyback Plan under the authorization approved on April 25, 2024. CI
28/05 Software Group Omda Launches NOK30 Million Share Buyback MT

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,065 1,803 796.8 765.6 735.2 - -
Enterprise Value (EV) 1 2,045 2,014 1,095 1,122 1,097 1,068 1,014
P/E ratio -223 x -20.2 x -6.05 x 7.43 x -31,304 x 45.6 x 16 x
Yield - - - - - - -
Capitalization / Revenue 8.99 x 5.45 x 2.16 x 1.84 x 1.65 x 1.53 x 1.41 x
EV / Revenue 8.9 x 6.09 x 2.96 x 2.7 x 2.46 x 2.22 x 1.95 x
EV / EBITDA 35.2 x 48.1 x 474 x 17.7 x 9.97 x 8.32 x 6.38 x
EV / FCF 1,446 x -736 x -21.6 x -415 x 15.7 x 12.6 x 10.9 x
FCF Yield 0.07% -0.14% -4.62% -0.24% 6.38% 7.96% 9.17%
Price to Book 8.29 x 10.8 x 27.7 x 8.14 x 7.41 x 6.36 x 3.68 x
Nbr of stocks (in thousands) 20,967 20,967 20,967 20,692 20,423 - -
Reference price 2 98.50 86.00 38.00 37.00 36.00 36.00 36.00
Announcement Date 26/02/21 25/02/22 28/02/23 01/03/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 207.2 229.8 330.7 369.7 415.1 446.7 481.3 521.2
EBITDA 1 - 58.14 41.83 2.307 63.26 110.1 128.4 159
EBIT 1 - 17.26 -39.54 -90.45 128.7 55.83 73.16 111
Operating Margin - 7.51% -11.96% -24.47% 31% 12.5% 15.2% 21.3%
Earnings before Tax (EBT) 1 - -8.009 -86.83 -136.3 103.4 1.673 21.21 60.64
Net income 1 -36.24 -9.226 -89.12 -131.6 104.4 -0.0418 16.54 47.3
Net margin -17.49% -4.01% -26.95% -35.6% 25.14% -0.01% 3.44% 9.08%
EPS 2 - -0.4413 -4.251 -6.276 4.977 -0.001150 0.7902 2.256
Free Cash Flow 1 - 1.414 -2.735 -50.6 -2.702 70 85 93
FCF margin - 0.62% -0.83% -13.69% -0.65% 15.67% 17.66% 17.85%
FCF Conversion (EBITDA) - 2.43% - - - 63.57% 66.18% 58.49%
FCF Conversion (Net income) - - - - - - 513.88% 196.61%
Dividend per Share 2 - - - - - - - -
Announcement Date 08/10/20 26/02/21 25/02/22 28/02/23 01/03/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 87.88 89.81 86.5 98.01 102.2 104.1 99.59 109.2 105.6 112.3 107.6 118.2 122
EBITDA 1 -2.756 - 4.725 -20.21 5.449 10.72 26.64 20.48 15.01 31 35 29 37
EBIT 1 -24.33 - -17.43 -47.85 -17.06 -11.69 13.04 6.572 0.991 19 23 17 25
Operating Margin -27.69% - -20.15% -48.82% -16.7% -11.22% 13.09% 6.02% 0.94% 16.92% 21.37% 14.39% 20.49%
Earnings before Tax (EBT) 1 -40.22 - -25.69 -63.18 1.569 -27.27 135.1 0.617 -13.52 4.275 9.28 3.135 12
Net income 1 -42.47 -19.72 -25.22 -58.72 2.783 -25.8 126.3 5.577 -13.24 3.335 7.238 2.445 9
Net margin -48.33% -21.96% -29.15% -59.91% 2.72% -24.77% 126.86% 5.11% -12.54% 2.97% 6.73% 2.07% 7.38%
EPS 2 -2.030 - -1.203 -2.800 - - - 0.2660 - 0.1608 0.3490 0.1179 0.4500
Dividend per Share 2 - - - - - - - - - - - - -
Announcement Date 25/02/22 30/08/22 30/11/22 28/02/23 12/05/23 25/08/23 10/11/23 01/03/24 14/05/24 - - - -
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 211 298 356 362 333 279
Net Cash position 1 - 20.3 - - - - - -
Leverage (Debt/EBITDA) - - 5.032 x 129.1 x 5.632 x 3.289 x 2.593 x 1.755 x
Free Cash Flow 1 - 1.41 -2.74 -50.6 -2.7 70 85 93
ROE (net income / shareholders' equity) - - -6.84% -135% 156% 14.5% 25.8% 26.4%
ROA (Net income/ Total Assets) - - - -17.4% 5.68% 2.1% 4.3% 5.3%
Assets 1 - - - 754.3 1,837 -1.99 384.7 892.5
Book Value Per Share 2 - 11.90 7.950 1.370 4.540 4.860 5.660 9.790
Cash Flow per Share - - - - - - - -
Capex 1 - 27.5 28.2 41.9 45.3 51 54 57
Capex / Sales - 11.98% 8.53% 11.32% 10.92% 11.42% 11.22% 10.94%
Announcement Date 08/10/20 26/02/21 25/02/22 28/02/23 01/03/24 - - -
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Omda

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
36 NOK
Average target price
46.5 NOK
Spread / Average Target
+29.17%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
OMDA Stock Omda
-2.43% 69.31M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-3.32% 30.09B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+45.72% 9.91B
SECTRA AB Stock Sectra AB
+36.80% 4.52B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-37.51% 2.39B
VERADIGM INC. Stock Veradigm Inc.
-7.53% 1.62B
OMNICELL, INC. Stock Omnicell, Inc.
-28.36% 1.22B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+6.41% 953M
LUNIT INC. Stock Lunit Inc.
-41.51% 936M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-45.19% 732M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. CSAM Stock
  4. Financials Omda